The Effect of Grinberg Method (GM) Intervention on Low-back Pain (LBP) and Improving the Quality of Life
Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Nov 17, 2011
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
The research will include 140 patients, who attended the pain clinic due to chronic LBP. Any change in the pharmacological regimen will be done with consult of the tending doctor and the change will be reported.
Tools and Methods A patient, whom volunteers to take part in the research, will be invited to the Ichilov Pain clinic in order to fill-in questionnaires and sign an informed consent form.
Each participant in the experiment group will participate in a series of 6 sessions lasting 1 hour each, extending between 6 to 8 consecutive weeks, with one of the qualified GM practitioners par...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Women and men, age range 18-65; patients of the Ichilov Pain clinic, who suffer from chronic LBP that lasts over 3 months and that appears several times a week.
- • LBP which is localized between the 12th rib and the inferior gluteal folds, with or without leg pain. The LBP may be non-specific, mechanical or radicular.
- Exclusion Criteria:
- • Patients with malignancy and/or other life threatening conditions
- • Diabetic patients
- • Patients with fibromyalgia
- • Pregnancy
- • Paralysis
- • Patients with obesity
- • Patients that underwent organ transplantation
- • Severe osteoporosis
- • Patients that are scheduled to receive spinal cord injections during the research
- • Patients that received less than 4 weeks before the research, other pain interventions than the standard of care treatment such as: alternative medicine (acupuncture, shiatsu, massage, reflexology, homeopathy etc'); physiotherapy, chiropractic, hydrotherapy, bio-feedback, osteopathy and others.
- • Patients with severe mental disorders (such as schizophrenia, bipolar disorder, suicidal tendencies etc')
- • Pain lasting less than 3 months
About Tel Aviv Sourasky Medical Center
Tel Aviv Sourasky Medical Center, a leading academic medical institution in Israel, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a multidisciplinary approach, the center integrates cutting-edge medical technology and evidence-based practices to enhance patient care and outcomes. Its robust infrastructure supports a diverse range of clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. The center's dedication to research excellence and patient safety positions it as a key player in the global clinical research landscape, driving advancements in medical knowledge and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
Patients applied
Trial Officials
Silviu Brill, MD
Principal Investigator
Tel-Aviv Sourasky Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials